REGENXBIO Inc. (Nasdaq: RGNX) highlighted progress and upcoming anticipated milestones across its pipeline of AAV gene therapies for rare and retinal diseases. "2026 is set to be a transformative year ...

Lucid Capital Markets is acting as the sole book-running manager for the proposed offering.

Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at ...

For reasons that are more than just obvious, the state education department has been at the receiving end of some of the most withering criticisms from the Naga ...

Virginia’s Employment Commission has transformed operations, cutting appeals processing from months to days, boosting first ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

More than 10,000 Bendigo residents have just days to enrol or update their details to vote in the upcoming council byelection ...